In his doctoral dissertation completed at the University of Jyväskylä, Finland, Tero Sievänen demonstrates that the cancer risk of Lynch syndrome carriers can be assessed based on circulating microRNA profiles.
Lynn Seely brings ex-Myovant colleague to Lyell’s C-suite; Nkarta, Zai Lab name new CFOs
→ Lyell Immunopharma, the cell therapy shop co-founded and chaired by Rick Klausner that made the Endpoints 11 in 2020, has tapped Matthew Lang as
July 8, 2023